Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Digital Mammography: Undergo DM
Digital Tomosynthesis Mammography: Undergo TM
Laboratory Biomarker Analysis: Correlative studies
Study summary
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Eligibility
Primary outcome measure(s)
- Proportion of women diagnosed with an advanced breast cancer at any time during a period of 4.5 years from randomization, including the period of active screening and a period of follow up after the last screen — 4.5 years after last registration
The cumulative proportions of participants experiencing the primary endpoint in the two study arms will be compared. The primary comparison of the two study arms will be approached from an Intent-to-Treat perspective and will be based on a two-sided test for comparing binomial proportions.
Trial sites (149)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Alabama at Birmingham Cancer Center | Birmingham | Alabama | |
| Mobile Infirmary Medical Center | Mobile | Alabama | |
| Banner-University Medical Center Phoenix | Phoenix | Arizona | |
| University of Arizona College of Medicine Phoenix | Phoenix | Arizona | |
| Valleywise Comprehensive Health Center - Phoenix | Phoenix | Arizona | |
| Mayo Clinic Hospital in Arizona | Phoenix | Arizona | |
| Scottsdale Medical Imaging Limited | Scottsdale | Arizona | |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | |
| Kern Radiology Medical Group Inc | Bakersfield | California | |
| Los Angeles General Medical Center | Los Angeles | California | |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | |
| Kaiser Permanente-Modesto | Modesto | California | |
| Zuckerberg San Francisco General Hospital | San Francisco | California | |
| UCHealth University of Colorado Hospital | Aurora | Colorado | |
| Penrose-Saint Francis Healthcare | Colorado Springs | Colorado | |
| The Women's Imaging Center | Denver | Colorado | |
| Radiology Imaging Associates | Englewood | Colorado | |
| UCHealth Highlands Ranch Hospital | Highlands Ranch | Colorado | |
| UCHealth Lone Tree Health Center | Lone Tree | Colorado | |
| Helen F Graham Cancer Center | Newark | Delaware | |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | |
| University of Florida Health Science Center - Jacksonville | Jacksonville | Florida | |
| Northside Hospital | Atlanta | Georgia | |
| Northeast Georgia Medical Center Braselton | Braselton | Georgia | |
| Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Savannah | Georgia | |
| Queen's Medical Center | Honolulu | Hawaii | |
| Saint Alphonsus Cancer Care Center-Boise | Boise | Idaho | |
| Saint Luke's Cancer Institute - Boise | Boise | Idaho | |
| Bromenn Lifecare Center | Bloomington | Illinois | |
| John H Stroger Jr Hospital of Cook County | Chicago | Illinois | |
| Carle at The Riverfront | Danville | Illinois | |
| Carle on Fairchild | Danville | Illinois | |
| Decatur Memorial Hospital | Decatur | Illinois | |
| Carle Hoopeston Regional Health Center | Hoopeston | Illinois | |
| Carle Physician Group-Mattoon/Charleston | Mattoon | Illinois | |
| Bromenn Regional Medical Center | Normal | Illinois | |
| Carle Cancer Center | Urbana | Illinois | |
| Saint Mary Medical Center | Hobart | Indiana | |
| Indiana University/Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | |
| The Community Hospital | Munster | Indiana |
+ 109 more sites — see the full list on the official registry below.
More ECOG-ACRIN Cancer Research Group trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03233191 on ClinicalTrials.gov ↗ ← All trials in South Korea